Insilico & HLFM: AI for Human Longevity Science

May 27·0:00 listen·Source: BioPharma APAC

Summary

Insilico Medicine and Human Life Foundation Models, Inc., or HLFM, are launching a multi-million-dollar AI collaboration. They aim to build the industry's first large-scale foundation models for human longevity science. This partnership will develop a super-intelligence AI foundation model to understand aging and enable predictive healthcare. Insilico will contribute its expertise in multimodal foundation model development and deep learning system engineering. HLFM will integrate these tools with Human Longevity's extensive multi-omic and clinical datasets. These datasets include multi-omics, imaging, and health records from thousands of individuals. The goal is for these models to be commercially available. They are expected to drive breakthroughs in early detection of age-related diseases, predictive health risk modeling, and the discovery of new therapeutics. This collaboration highlights a shift towards proactive and preventive longevity science in healthcare.

Read the full article on BioPharma APAC

This is an AI-generated audio summary. Always check the original source for complete reporting.

Share
Keep Listening